How does the Q2 2025 net loss/earnings per share compare to the same quarter last year and to the market's expectations?

Answer

The press‑release you quoted only gives a snapshot of Nektar Therapeutics’ balance‑sheet (cash and marketable‑securities) as of June 30 2025. It does not include the company’s net loss (or net income) for the quarter, nor the earnings‑per‑share (EPS) figure that investors and analysts use to compare performance to prior periods and to consensus expectations.

Because the net loss/EPS numbers are missing, we can’t calculate:

What you would need to answer the question

1. Net loss (or net income) for Q2 2025 – usually reported as “Net loss of $ X million (or net income of $ Y million).”
2. EPS (or loss per share) for Q2 2025 – reported as “Loss per share of $ Z” (or “ earnings per share of $ Z” if the company turned a profit).
3. Net loss/EPS for Q2 2024 – the same figures from the prior year’s second‑quarter filing, so the change can be measured.
4. Market expectations – the consensus estimate that Wall‑Street analysts had published before the company released its results (e.g., “Analysts expected a net loss of $ A million, or a loss per share of $ B”).

Typical way the comparison is presented in a press‑release

“Net loss for the quarter was $ 85.3 million, or $ 0.71 per share, compared with a net loss of $ 73.1 million, or $ 0.61 per share, in Q2 2024. The result was *worse than** analysts’ consensus estimate of a $ 0.65 loss per share.”*

or, if the company beat expectations:

“Net loss for the quarter was $ 65.2 million, or $ 0.55 per share, *narrowly better** than the consensus estimate of a $ 0.60 loss per share and an improvement from the $ 0.71 loss per share recorded in Q2 2024.”*

What to do next

• Locate the full Nektar Therapeutics Q2 2025 earnings release (often posted on the company’s investor‑relations website or on the PRNewswire distribution). The release will contain the net loss and EPS figures, plus a “Financial Highlights” table that typically lists “Net loss (loss per share)” and “Year‑over‑year change.”
• Check analyst consensus on a platform such as Bloomberg, FactSet, Thomson Reuters, or Yahoo! Finance. Those services publish the “Expected EPS” that the market had forecast before the filing.
• Once you have those numbers, you can compute the percentage change versus Q2 2024 and state whether the result was in line with, above, or below market expectations.

Bottom line: With the current excerpt you provided, the net loss/EPS data needed for a direct comparison are not available. You’ll need to retrieve the complete earnings release (or a reliable earnings‑summary article) that includes those figures, and then compare them to the prior‑year quarter and to the analyst consensus.